Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article

Molecular residual disease (MRD), detected by circulating tumor DNA (ctDNA) can be involved in the entire process of solid tumor management, including recurrence prediction, efficacy evaluation, and risk stratification. Currently, the detection technologies are divided into two main categories, as f...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer biology & therapy 2023-12, Vol.24 (1), p.2274123-2274123
Hauptverfasser:	Dong, Qiantong, Chen, Chenbin, Hu, Yuanbo, Zhang, Weiteng, Yang, Xinxin, Qi, Yingxue, Zhu, Chan, Chen, Xiaodong, Shen, Xian, Ji, Weiping
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!